New treatment option for White Spot Lesions
Official title Comparison of MI Paste Plus and Resin Infiltration in White Spot Lesions Following Orthodontic Treatment
ClinicalTrials.gov ID: NCT05733676
What this study is testing
- What it's testing
- Dental cavities are among the most frequent diseases that affect teeth, particularly in patients who are treated with braces due to the difficulty in maintaining good oral hygiene in the presence of the mouth appliances. The white spot lesion (WSL) is the first clinical sign of cavities that presents itself as a milky-white opacity when located on the front face of the tooth.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 21. Healthy volunteers may be eligible.
You may be able to join if
- Individuals in the age range of 12-21 years who had undergone fixed orthodontic appliance therapy for a duration of 12-36 months.
- Should have at least one white spot lesion on the labial surface of either maxillary or mandibular anterior teeth after debonding. Lesion visible...
- Patients with mild to moderate plaque accumulation. Fair oral hygiene. With a simplified Oral Hygiene Index of no more than 1.3-3.0
You likely can't join if
- Poor oral hygiene Simplified Oral Hygiene Index of 3.1-6.0 or more
- Patients with hypoplasia or any developmental defects on the buccal of upper or lower incisors
- Patients with any restorations on the buccal of upper or lower incisors
- Patients that have presented WSL on the buccal of upper or lower incisors before orthodontic treatment was initiated.
- Patients that have received any re-mineralizing agent other than regular toothpaste during the last three months
- Patient with allergy to milk or any of their products
See the full eligibility criteria
- Individuals in the age range of 12-21 years who had undergone fixed orthodontic appliance therapy for a duration of 12-36 months.
- Should have at least one white spot lesion on the labial surface of either maxillary or mandibular anterior teeth after debonding. Lesion visible with or without drying the lesion surface.
- Patients with mild to moderate plaque accumulation. Fair oral hygiene. With a simplified Oral Hygiene Index of no more than 1.3-3.0
- Poor oral hygiene Simplified Oral Hygiene Index of 3.1-6.0 or more
- Patients with hypoplasia or any developmental defects on the buccal of upper or lower incisors
- Patients with any restorations on the buccal of upper or lower incisors
- Patients that have presented WSL on the buccal of upper or lower incisors before orthodontic treatment was initiated.
- Patients that have received any re-mineralizing agent other than regular toothpaste during the last three months
- Patient with allergy to milk or any of their products
- Patient with any medical / oral or mental condition
- Patients or legal guardians that does not speak or read English
The study team makes the final eligibility decision.
Where it's taking place
- Edmonton, Alberta, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 21 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Edmonton, Alberta, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.